StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) stock

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.19−0.01 (-5.56%)

Close on Nov 17, 2026Market cap $2.58MP/E –Yield –

VolitionRx total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

VolitionRx's total debt was $7.05M at Jun 30, 2026. For fiscal 2025 it was $6.71M, up 39.4% from the year before. The highest annual figure on record is $6.71M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.71M+39.4%
FY2024Dec 31, 2024$4.81M-0.4%
FY2023Dec 31, 2023$4.83M+25.6%
FY2022Dec 31, 2022$3.85M+25.3%
FY2021Dec 31, 2021$3.07M-11.0%
FY2020Dec 31, 2020$3.45M+21.3%
FY2019Dec 31, 2019$2.84M+18.4%
FY2018Dec 31, 2018$2.40M+36.7%
FY2017Dec 31, 2017$1.76M+279.7%
FY2016Dec 31, 2016$462.68K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$7.05M+3.9%
Q1 FY2026Mar 31, 2026$7.29M+14.0%
Q4 FY2025Dec 31, 2025$6.71M+39.4%
Q3 FY2025Sep 30, 2025$6.48M+34.9%
Q2 FY2025Jun 30, 2025$6.79M+38.3%
Q1 FY2025Mar 31, 2025$6.39M+41.4%
Q4 FY2024Dec 31, 2024$4.81M-0.4%
Q3 FY2024Sep 30, 2024$4.80M+43.6%
Q2 FY2024Jun 30, 2024$4.91M+34.4%
Q1 FY2024Mar 31, 2024$4.52M+23.2%
Q4 FY2023Dec 31, 2023$4.83M+25.6%
Q3 FY2023Sep 30, 2023$3.34M+0.1%
Q2 FY2023Jun 30, 2023$3.65M+29.1%
Q1 FY2023Mar 31, 2023$3.67M+9.1%
Q4 FY2022Dec 31, 2022$3.85M+25.3%
Q3 FY2022Sep 30, 2022$3.34M+19.8%
Q2 FY2022Jun 30, 2022$2.83M-7.0%
Q1 FY2022Mar 31, 2022$3.37M+4.1%
Q4 FY2021Dec 31, 2021$3.07M-11.0%
Q3 FY2021Sep 30, 2021$2.79M+7.4%
Q2 FY2021Jun 30, 2021$3.04M+16.7%
Q1 FY2021Mar 31, 2021$3.23M+20.8%
Q4 FY2020Dec 31, 2020$3.45M+21.3%
Q3 FY2020Sep 30, 2020$2.60M+12.7%
Q2 FY2020Jun 30, 2020$2.61M+3.5%
Q1 FY2020Mar 31, 2020$2.68M+18.1%
Q4 FY2019Dec 31, 2019$2.84M+18.4%
Q3 FY2019Sep 30, 2019$2.30M+4.3%
Q2 FY2019Jun 30, 2019$2.52M+11.5%
Q1 FY2019Mar 31, 2019$2.26M+27.9%
Q4 FY2018Dec 31, 2018$2.40M+36.7%
Q3 FY2018Sep 30, 2018$2.21M+51.4%
Q2 FY2018Jun 30, 2018$2.26M+87.8%
Q1 FY2018Mar 31, 2018$1.77M+133.6%
Q4 FY2017Dec 31, 2017$1.76M+279.7%
Q3 FY2017Sep 30, 2017$1.46M–
Q2 FY2017Jun 30, 2017$1.20M–
Q1 FY2017Mar 31, 2017$758.39K–
Q4 FY2016Dec 31, 2016$462.68K–

More VolitionRx figures

See a number that looks wrong?